Hip
Senior Member
- Messages
- 18,109
The US Congress awarded $1.15 billion in funding over four years to the NIH for research into long COVID (ref: here). So that's about $250 million per year of long COVID research funding.
Whereas at present, the NIH only gives $17 million a year for research funding in ME/CFS.
$17m is a very small amount, as the NIH gives Parkinson's $263m a year, MS $126m, Alzheimer's $3059m, autism $288m, PTSD $142m and ADHD $72m (ref: here).
Given that long COVID is a very similar disease to ME/CFS, is there be any legal basis by which ME/CFS patients and ME/CFS researchers could claim the same sort of funding level from Congress?
Would it be possible to take legal action against the government in order to obtain research funding parity between LC and ME/CFS. Or set up some sort of petition asking the government to review its funding?
Do we have any legal experts here?
Some argue that because LC and ME/CFS are so similar in their symptoms, any research findings and treatments for LC may benefit ME/CFS patients also.
While that may be the case, it is also possible that long COVID may have a completely different pathophysiology to ME/CFS. So in this case LC research may yield treatments that work for LC patients and the coronavirus infection that may be driving LC, but which may not work for ME/CFS patients whose illness is associated with other viruses like enteroviruses or herpesviruses.
Thus a cure or effective treatment for LC may soon be forthcoming as a result of this massive $1.15 billion investment into long COVID research, but regular ME/CFS patients may not benefit from that treatment.
This does not seem right, given that LC and ME/CFS have very similar symptoms, and are equally debilitating. So the ME/CFS patient community may want to start thinking about what we can do regarding this research funding inequality, and how we can get funding parity with LC patients.
Decisions made by public bodies such as governments are bound by certain laws. One of the legal requirements is that decisions must be rational and evidence-based.
It would not be rational to award patients with one subset of ME/CFS (the long COVID subset) a massive amount of research money in order to find the cause and cure of their illness, while awarding 15 times less money to patients from another ME/CFS subset (the regular ME/CFS patients).
How could such as decision ever be seen as rational and evidence-based? Therefore I think we can conclude that there may be a basis for the government acting contrary to law.
Whereas at present, the NIH only gives $17 million a year for research funding in ME/CFS.
$17m is a very small amount, as the NIH gives Parkinson's $263m a year, MS $126m, Alzheimer's $3059m, autism $288m, PTSD $142m and ADHD $72m (ref: here).
Given that long COVID is a very similar disease to ME/CFS, is there be any legal basis by which ME/CFS patients and ME/CFS researchers could claim the same sort of funding level from Congress?
Would it be possible to take legal action against the government in order to obtain research funding parity between LC and ME/CFS. Or set up some sort of petition asking the government to review its funding?
Do we have any legal experts here?
Some argue that because LC and ME/CFS are so similar in their symptoms, any research findings and treatments for LC may benefit ME/CFS patients also.
While that may be the case, it is also possible that long COVID may have a completely different pathophysiology to ME/CFS. So in this case LC research may yield treatments that work for LC patients and the coronavirus infection that may be driving LC, but which may not work for ME/CFS patients whose illness is associated with other viruses like enteroviruses or herpesviruses.
Thus a cure or effective treatment for LC may soon be forthcoming as a result of this massive $1.15 billion investment into long COVID research, but regular ME/CFS patients may not benefit from that treatment.
This does not seem right, given that LC and ME/CFS have very similar symptoms, and are equally debilitating. So the ME/CFS patient community may want to start thinking about what we can do regarding this research funding inequality, and how we can get funding parity with LC patients.
Decisions made by public bodies such as governments are bound by certain laws. One of the legal requirements is that decisions must be rational and evidence-based.
It would not be rational to award patients with one subset of ME/CFS (the long COVID subset) a massive amount of research money in order to find the cause and cure of their illness, while awarding 15 times less money to patients from another ME/CFS subset (the regular ME/CFS patients).
How could such as decision ever be seen as rational and evidence-based? Therefore I think we can conclude that there may be a basis for the government acting contrary to law.
Last edited: